Scinai Immunotherapeutics (SCNI) Retained Earnings (2015 - 2026)
Scinai Immunotherapeutics (SCNI) posted Retained Earnings of -$122.3 million for Q1 2026, up 2.84% sequentially from -$125.8 million in Q4 2025.
Scinai Immunotherapeutics (SCNI) Retained Earnings (2015 - 2026) Analysis & Trends
Scinai Immunotherapeutics has reported Retained Earnings for 12 years, with the latest figure at -$122.3 million in Q1 2026.
- Quarterly Retained Earnings changed N/A year-over-year to -$122.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$122.3 million (changed N/A YoY) and the FY2025 annual result came in at -$125.8 million, down 201.79% from the prior year.
- Retained Earnings climbed to -$122.3 million in Q1 2026 per SCNI's latest filing, from -$125.8 million in the prior quarter.
- Over five years, Retained Earnings peaked at $123.6 million in Q4 2024 and troughed at -$126.8 million in Q2 2024.
- A 5-year average of -$87.9 million and a median of -$120.0 million in 2023 frame the typical range for Retained Earnings.
- The sharpest annual moves came in 2023 and 2024: Retained Earnings tumbled 205.39% in 2023, then surged 201.06% in 2024.
- Over 5 years, Retained Earnings stood at $116.1 million in 2022, then sank by 205.39% to -$122.3 million in 2023, then soared by 201.06% to $123.6 million in 2024, then sank by 201.79% to -$125.8 million in 2025, then increased by 2.84% to -$122.3 million in 2026.
- According to Business Quant data, Retained Earnings over the past three periods registered -$122.3 million, -$125.8 million, and -$121.7 million for Q1 2026, Q4 2025, and Q2 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 15.69 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 37.62 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 558.00 Mn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 5.10 Bn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 13.05 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | -6.33 Bn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 20.91 Bn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 6.57 Bn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 4.38 Bn |
| 10 | Scinai Immunotherapeutics | 11.72 Mn | -3.10 Bn | -1.12 Mn | -122.27 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -122.27 Mn |
| Dec 31, 2025 | -125.85 Mn |
| Jun 30, 2025 | -121.67 Mn |
| Dec 31, 2024 | 123.63 Mn |
| Sep 30, 2024 | -115.31 Mn |
| Jun 30, 2024 | -126.82 Mn |
| Mar 31, 2024 | -124.49 Mn |
| Dec 31, 2023 | -122.34 Mn |
| Sep 30, 2023 | -120.01 Mn |
| Jun 30, 2023 | -123.11 Mn |
| Mar 31, 2023 | -119.35 Mn |
| Dec 31, 2022 | 116.08 Mn |
| Sep 30, 2022 | -108.18 Mn |
| Jun 30, 2022 | -110.58 Mn |
| Mar 31, 2022 | -117.82 Mn |
| Dec 31, 2021 | 113.08 Mn |
| Sep 30, 2021 | -109.64 Mn |
| Jun 30, 2021 | -344.97 Bn |
| Mar 31, 2021 | -332.98 Bn |
| Dec 31, 2020 | -324.79 Bn |